Two patients received long‐term TMZ chemotherapy before surgery, and mutations in the SHh (PTCH1) and PI3K/AKT signaling pathways (AKT1, PIK3CA, PTPN11) were detected in two tumor tissues (Patients 24 and 27) (Figure 2C,D). The gene discussed is AKT1; the disease is neoplasm.